A research team has developed a multi-medium approach (MMA) to identify reproducible volatile organic compounds (VOCs) in ...
The study from The Hebrew University of Jerusalem, led by Prof. Sheera Adar and her graduate student Elisheva Heilbrun-Katz ...
The World Health Organization is issuing new guidance over warning labels that it believes should be put on alcoholic drinks ...
Aging is a privilege, but it also brings risks—including an increased likelihood of developing age-related diseases including ...
EVENTS DURING THE FOURTH QUARTEREuropean Patent Office granted Active Biotech's patent application for eye drop formulation of laquinimod (October 23)Active Biotech's clinical trial of tasquinimod in ...
Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.